| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
* First Department of Internal Medicine, Kansai Medical University, Osaka, Japan;
First Department of Pathology, Kansai Medical University, Osaka, Japan;
First Department of Internal Medicine, Kyoto University, Kyoto, Japan;
Department of Obstetrics and Gynecology, Kansai Medical University, Osaka, Japan; and
¶ Department of Animal Development and Physiology, Graduate School of Biostudies, Kyoto University, Kyoto, Japan
 |
Abstract |
|---|
 Top Abstract IntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
in response to T cell stimulation (CD40 ligand or T cell interaction), resulting in the preferential priming of Th2 cells through OX40L-dependent mechanisms. Meanwhile, PDCs were rapidly endowed by viral infection (Sendai virus) with a high potency to develop IFN-
-producing Th cells depending on their capacity to residually produce IFN-. Although Sendai virus-stimulated PDCs simultaneously expressed OX40L in their maturational process, the Th1-inducing effect of endogenous type I IFNs may overcome and thus conceal the OX40L-dependent Th2 responses. However, during maturation in response to Sendai virus over the longer 72-h period, the expression level of OX40L was up-regulated, whereas the residual IFN--producing ability was down-regulated, and consequently, the PDCs with prolonged Sendai virus stimulation induced Th2 responses to some extent. Thus, PDCs have the distinct means to dictate an appropriate response to environmental stimuli. |
Introduction |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
-producing cells (1, 2), are dendritic cell (DC) precursors (3, 4). IL-3 or viral infection can trigger PCs to develop into DCs, which can initiate Th cell responses (5, 6, 7). In immune responses, the functional properties of PCs are altered during their maturational process; PCs act as type I IFN producers in enhancing innate immunity at microbial recognition and develop into DCs (plasmacytoid DCs (PDCs)), which eventually act as APCs in adaptive immunity (2, 5, 6). To provide the essential functions in priming naive T cells in lymphoid tissues, PDCs require CD40 ligands (CD40L), which are delivered from T cells and cause the terminal maturation of DCs (3, 4).
Recent research has clarified the functional plasticity of DCs in determining T cell responses (8, 9). Most myeloid DC subsets have some capacity to produce IL-12 and thereby to induce Th1 development. However, this capacity varies with their stage of maturation and the environmental stimuli delivered to them (10, 11, 12). In contrast, when PCs sense viruses, they rapidly produce a large amount of IFN- and differentiate into DCs, which can facilitate Th1 cell development (6, 7). Meanwhile, IL-3-treated PDCs favor Th2 cell responses (4, 6, 13). However, it remains largely unknown how PDCs dictate the type of Th cell response. Upon viral infection, PCs produce IFN-, which is responsible for IFN- production by T cells (6, 7). In contrast, we still do not know which PDC-derived factors actively induce Th2 development. One possible mechanism underlying the Th2 development by PDCs is the default mechanism due to the lack of Th1-inducing cytokines such as IL-12 or IFN-. However, a previous study has shown that the addition of IL-12 to the coculture of Th cells and PDCs preincubated with IL-3 plus CD40L increases the frequency of IFN--producing Th cells, but does not decrease the frequency of IL-4-producing Th cells (4). Thus, the default mechanism mentioned above cannot completely explain this issue.
Several studies have pointed to the role of the OX40-OX40 ligand (OX40L) pathway, which selectively regulates Th2 cell development in mice (14, 15, 16, 17, 18, 19) and humans (20, 21). OX40 is expressed on activated CD4+ T cells (22, 23), whereas OX40L is induced on activated mouse CD11c+ DCs (24, 25) and human monocyte-derived DCs (23, 26). The stimuli triggered by OX40L on these DCs elicit a costimulatory role in preferential priming of Th2 cells (24, 25, 27). However, it is not clear at present whether OX40L is induced on human PDCs or whether it exhibits costimulatory functions in the PDC-mediated Th2 responses.
Monocyte-derived DCs can produce IL-12 for a limited time soon after activation (10). Similarly, PCs/PDCs can actively produce IFN- only within a limited time after microbial stimulation (1, 28, 29), suggesting that the Th1-polarizing capacity of PDCs is dependent on the duration of the stimulus. In this study we investigate the kinetics of OX40L expression and IFN- production in PDCs in response to the two major PDC-stimulating factors, IL-3 and viruses, and assess their functional roles in the regulation of the quality of Th responses.
|
Materials and Methods |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
RPMI 1640 supplemented with 2 mM L-glutamine, 100 U/ml penicillin, 100 ng/ml streptomycin, and heat-inactivated 10% FCS (Irvine Scientific, Santa Ana, CA) was used for the cell culture throughout the experiments. Recombinant human IL-3 (10 ng/ml; PeproTech EC, London, U.K.), bacurovirus-expressed soluble CD40 ligand (sCD40L: trimer form, 1/100 dilution) (30, 31), and UV-irradiated Sendai virus (at 5 hemagglutinating units/ml; HVJ: Cantell strain, provided by Sumitomo Pharmaceuticals, Ehime, Japan) were used for cell cultures. The mAb against human OX40L/gp34, ik-1 (mouse IgG1) (23, 32), was used for analysis of surface expression on cells and for neutralization of the OX40/OX40L pathway in DC-T cell coculture.
Isolation of blood PCs
Peripheral blood PCs were isolated according to the modified protocol described previously (13, 33, 34). Briefly, the DC-enriched population (CD4+/CD3-/CD14- cells) was obtained from PBMCs by negative and subsequent positive immunoselection. The CD11c-/lineage-/DR+ cells (PCs) were sorted by an EPICS ALTRA flow cytometer (Coulter, Hialeah, FL) using PE-labeled anti-CD11c (Leu-M5; BD Biosciences, Sunnyvale, CA); a mixture of FITC-labeled mAbs against lineage markers, CD3 (M2AB; Exalpha, Boston, MA), CD14 (FWKW-1; Exalpha), CD15 (Leu-M1; BD Biosciences), CD16 (J5511; Exalpha), CD19 (SJ25C1; BD Biosciences), and CD56 (NCAM16.2; BD Biosciences); and PE-cyanin 5.1 (PC5)-labeled HLA-DR (Immu-357; ImmunoTech, Marseilles, France). The purity of PCs was >98%.
Analyses of T cell polarization stimulated by PDCs
CD4+/CD45RA+ naive T cells were obtained from allogeneic healthy volunteers using a CD4+ T cell isolation kit (Miltenyi Biotec, Bergisch Gladbach, Germany), followed by positive selection with CD45RA-conjugated microbeads (Miltenyi Biotec) or sorting with staining of PE-labeled CD45RA mAb (HI100; BD Biosciences). The purity of the cells was 95% or greater by reanalysis. PDCs preincubated with IL-3 or Sendai virus for 24 or 72 h were washed and then cocultured with allogeneic CD4+/CD45RA+ naive T cells (105 cells/well; DC-T ratio, 1:5) in 96-well, round-bottom, tissue culture plates. In some experiments a mixture of neutralizing rabbit polyclonal anti-human IFN- Ab (2000 neutralization units/ml), neutralizing rabbit polyclonal anti-human IFN- Ab (1000 neutralization units/ml), mouse anti-human IFN- receptor mAb (20 µg/ml; PBL Biomedical Laboratories, New Brunswick, NJ), and/or anti-OX40L mAb (ik-1; 50 µg/ml) was added to the coculture. Heat-inactivated rabbit serum (Vector Laboratories, Burlingame, CA) and mouse IgG1 (R&D Systems, Minneapolis, MN) were used as a control. Seven days after coculture, T cells were washed and restimulated with PMA (50 ng/ml) and ionomycin (2 µg/ml) at 106 cells/ml for 24 h for ELISA or 6 h for intracellular cytokine staining. ELISA kits for IFN-, IL-4, IL-5, and IL-13 (R&D Systems) were used to analyze T cell cytokine production. For intracellular cytokine analyses, brefeldin A (10 µg/ml) was added during the last 2 h. The cells were stained with PE-cyanin 5.1 (PC5)-labeled anti-CD4 (ImmunoTech), then with PE-labeled anti-IL-4 (BD Biosciences) plus FITC-labeled anti-IFN- mAb (BD Biosciences) using FIX and PERM kit (Caltag Laboratories, Burlingame, CA).
Measurements of IFN- production from PDCs
The sorted blood PCs were cultured with IL-3 or Sendai virus for 24 or 72 h in 96-well, round-bottom, tissue culture plates at 5 x 104 cells in 200 µl of medium/well. After removal of each supernatant and washing, the adjusted number of cells were recultured with medium alone or restimulated with sCD40L or allogeneic CD4+/CD45RA+ cells (5 x 104 PDCs/5 x 104 T cells/200 µl) for an additional 24 h, respectively, and the supernatants were collected. The production of IFN- and IL-12 p70 in the supernatants was determined by ELISA (Endogen, Woburn, MA).
Analyses of expression of OX40L and costimulatory molecules
Total RNA was prepared from freshly isolated PCs and PDCs after culture using TRIzol reagent (Life Technologies, Grand Island, NY). RT reactions were performed on 2 µg of total RNA using an oligo(dT) primer with SuperScript II (Life Technologies). One-microliter aliquots of the DNA resulting from each RT reaction were subjected to PCR. The temperature profiles of PCR were as follows: an initial denaturation step of 94°C for 5 min, followed by 30 cycles of 94°C for 1 min, 55°C for 1 min, 72°C for 1 min, and a final elongation step of 72°C for 7 min. The sequences of primers were as follows: OX40L: forward, 5'-CCCAGATTGTGAAGATGGAA-3'; and reverse, 5'-GCCTGGTTTTAGATATTGCC-3'; and -actin: forward, 5'-GACCCAGATCATGTTTGAGACCTTCAACAC-3'; and reverse, 5'-TACTTGCGCTCAGGAGGAGCAATGATCTTG-3'. A 
X174 DNA-HaeIII digest (New England Biolabs, Beverly, MA) was used as a DNA size marker. To evaluate surface OX40L expression, the cells were stained with anti-OX40L mAb (ik-1) or isotype-matched control mAb, followed by PE-labeled goat anti-mouse IgG (BD Biosciences). To analyze the expression of costimulatory molecules, the cells were stained with FITC-labeled anti-CD40 (5C3; BD Biosciences), CD86 (2331; BD Biosciences), or CD80 (BB-1; Ancell, Bayport, MN) and analyzed with a FACScan (BD Biosciences).
|
Results |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
We first analyzed PDC functions in polarizing Th cells when PDCs were stimulated with IL-3 or Sendai virus for 1 or 3 days. The costimulatory molecules (CD40, CD80, and CD86), which are the hallmarks of DC differentiation, were up-regulated modestly on PDCs by IL-3 during 1-day culture and were further up-regulated during 3-day culture (Fig. 1A). Sendai virus readily up-regulated all markers after the 1-day culture, indicating that Sendai virus rapidly induces PDCs to differentiate into mature DCs. These PDCs were cocultured with allogeneic CD4+ naive T cells for 7 days, and the cytokine profiles of the activated Th cells were examined by intracellular staining (Fig. 1B) and ELISA analysis of the culture supernatants (Fig. 1C). PDCs pretreated with IL-3 for 1 day (1d-IL-3-PDCs) could stimulate naive Th cells to develop into the polarized (IL-4- or IFN--producing) Th cells to a certain extent (Fig. 1B). Compared with 1d-IL-3-PDCs, 3d-IL-3-PDCs increased the frequency of IL-4-producing cells, as determined by intracellular staining (Fig. 1B), and also induced the higher amounts of IL-4, IL-5, and IL-13 production (Fig. 1C) in Th cells. In contrast, PDCs prestimulated with Sendai virus for 1 day (1d-SV-PDCs) showed a high potency to preferentially induce IFN--producing T cell development, but induced low levels of IL-4, IL-5, and IL-13 production in Th cells. Compared with 1d-SV-PDCs, 3d-SV-PDCs developed a comparable level of IFN- production in Th cells. However, they concomitantly induced an increased number of IL-4-producing T cells (Fig. 1B) and moderate levels of IL-4, IL-5, and IL-13 production (Fig. 1C) in Th cells. These findings indicate that PDCs cultured with IL-3 can preferentially induce Th2 cells, and that viral infection rapidly equips PDCs with the ability to evoke IFN- production in Th cells. In addition, as a result of prolonged stimulation with Sendai virus, PDCs acquire a moderate ability to induce Th2 cells.
|
in PDCs in response to Sendai virus
PCs are the major source of IFN-, which not only plays a central role in inducing innate immunity against microbial infections but can also facilitate Th1 development in adaptive immunity (35, 36, 37). However, it is likely that the capacity of PCs to produce IFN- is transient (1, 28, 29). Therefore, to clarify whether PDC-derived IFN- actually participates in the Th cell priming, we next investigated whether the Sendai virus-infected PDCs have a residual capacity to produce IFN- when subsequently stimulated with sCD40L or allogeneic naive CD4+ T cells. Freshly isolated PCs can produce a large amount of IFN- in response to Sendai virus during the first 24 h (14,851 ± 1,225 pg/ml; n = 4), but cannot produce any under culture with IL-3 (<3 pg/ml; n = 4; Fig. 2A). This result is in line with previous studies (1, 2, 34). As shown in Fig. 2B, 1d-SV-PDCs could still residually produce a substantial amount of IFN- during the following 24 h, although their ability to produce IFN- was not significantly increased when subsequently stimulated by sCD40L or when cocultured with allogeneic naive Th cells. In contrast, residual IFN- production by 3d-SV-PDCs was detectable, but at a much lower level than that of 1d-SV-PDCs. In contrast to Sendai virus-stimulated PDCs, IL-3-treated PDCs (both 1d-IL-3-PDCs and 3d-IL-3-PDCs) can barely produce IFN- even after the subsequent activation with CD40L or T cell interaction. No bioactive IL-12 p70 was detectable in any of the culture conditions described above (<3 pg/ml; n = 4; data not shown).
|
We next examined the expression of OX40L on PDCs after the culture with IL-3 or Sendai virus by RT-PCR (Fig. 3A) and flow cytometry (Fig. 3B). OX40L mRNA and its surface protein could not be detected in freshly isolated PCs. After 1-day culture, IL-3 induced PCs to express OX40L mRNA at a very low level, whereas Sendai virus induced it at a definitive level (Fig. 3A). Furthermore, the OX40L expression induced by IL-3 or Sendai virus was up-regulated by the presence of sCD40L. Consistent with this expression profile of OX40L mRNA, a fraction of the cells began to express surface OX40L after 1-day culture with IL-3, and a majority of the cells became OX40L-positive at low level even after 3-day culture. The addition of sCD40L up-regulated their OX40L expression. Meanwhile, Sendai virus readily induced OX40L on the majority of the cells even after the 1-day culture and up-regulated its expression during 3-day culture; sCD40L augmented its expression.
|
To elucidate how PDC-derived OX40L and IFN- impact the quality of Th cell responses, anti-OX40L Ab and/or a mixture of anti-IFN- Ab, anti-IFN- Ab, and anti-IFN- receptor Ab (anti-IFNs Abs) were primarily added to the PDC-T cell cocultures. As shown in Fig. 4, the addition of anti-OX40L Ab significantly decreased the production of IL-4, IL-5, and IL-13 in Th cells stimulated with 1d-SV-PDCs, 3d-SV-PDCs, and 3d-IL-3-PDCs. The addition of anti-OX40L Ab significantly decreased only IL-13 production of T cells in coculture with 1d-IL-3-PDCs. By contrast, the same Ab had no effect on IFN- production from T cells under any culture conditions. In parallel with the results from ELISA, intracellular cytokine staining demonstrated that the addition of anti-OX40L Ab hampered the development, which had been induced by 3d-IL-3-PDCs or 3d-SV-PDCs, of IL-4-producing Th cells without affecting the frequency of IFN--producers (Fig. 5). These findings indicate that OX40L on the PDCs is responsible for Th cell production of IL-4, IL-5, and IL-13, but not IFN-.
|
|
production and increased IL-4, IL-5, and IL-13 production by Th cells when primed with 1d-SV-PDCs or 3d-SV-PDCs (Fig. 4). The intracellular cytokine staining also showed an impairment of IFN--producing cell development and a concomitant increase in the number of IL-4-producing cells when anti-IFN Abs were added into the coculture of 1d-SV-PDCs and 3d-SV-PDCs (Fig. 5, third panels). The reduction of IFN- production (and also IFN--producing cells) by the neutralization of IFN- was more potently observed in the coculture of 1d-SV-PDCs than in that of 3d-SV-PDCs. A further addition of anti-OX40L Ab to anti-IFNs Abs counteracted the enhanced IL-4-producing cell development by IFN- neutralization (Fig. 5, bottom panels). However, in the coculture with 1d-IL-3-PDCs and 3d-IL-3-PDCs, the addition of anti-IFNs Abs barely altered the T cell production of cytokines (Figs. 4 and 5). These findings suggest that PDCs, in response to either IL-3 or Sendai virus, acquire some potential to induce OX40L-dependent Th2 responses, and that PDC-derived IFN-, in response to Sendai virus, interferes with the OX40L-dependent responses and consequently favors Th1-type responses. |
Discussion |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
not only induced IFN- production, but also inhibited Th2 cytokine production (36, 37), resulting in the preferential development of Th1-type immunity. We have also demonstrated that IL-3-treated PDCs, which are widely noted as Th2-inducible DCs (so-called DC2) (4), expressed OX40L (Fig. 3), but barely produced any IFN- (Fig. 2B). Indeed, the costimulatory function of OX40L on 3d-IL-3-PDCs was responsible for the preferential priming of Th2 cells (Figs. 4 and 5). However, even the immature 1d-IL-3-PDCs, which partially and weakly expressed OX40L, could induce Th2 cells to some extent, and the addition of anti-OX40L Ab could not completely block Th2 cytokine production in Th cells when stimulated by 3d-IL-3-PDCs. These findings suggest that mechanisms other than OX40L may also be involved in the PDC-mediated Th2 responses. In this regard, it should be noted that human monocyte-derived DCs can actively induce Th2 cell development independently of OX40L in response to cAMP up-regulators such as PGE2 or cholera toxin (11). In addition, there is evidence that Th2 development induced by monocyte-derived DCs is dependent not only on OX40-OX40L interaction, but also on the B7-CD28 costimulation pathway (27). Furthermore, a series of studies has suggested that the ICOS-ICOS ligand pathway plays an important role in Th2 development and function (38, 39, 40). Thus, multiple signals, including the OX40-OX40L pathway, may possibly cooperate to dictate Th2 development in the DC-mediated immune responses.
Like IL-3-treated PDCs, Sendai virus-stimulated PDCs substantially expressed OX40L (Fig. 3). However, they did not favor preferential Th2 responses, but actively promoted Th1-type immune responses according to their high potency to produce IFN- (Fig. 1, B and C, and Fig. 2), in accord with previous studies (6, 7). Considering the findings that the neutralization of IFN- inhibited IFN- production and supported OX40L-dependent Th2 responses when primed with 1d-SV-PDCs or 3d-SV-PDCs (Figs. 4 and 5), it might well be that the effect of PDC-derived IFN- predominates over that of OX40L in PDC-mediated immune responses upon viral infection. Thus, PDCs have the distinct means to control Th responses: IFN- as endogenous cytokines and OX40L as a costimulatory molecule, which differentially regulate T cell production of IFN- and Th2 cytokines, including IL-4, IL-5, and IL-13. Recent progress in DC biology has led to the concept that a given DC subset can alter its functional property depending on the microenvironment. The myeloid DC subset basically has the ability to induce immunogenic Th1 immune responses against microbial invasion in an IL-12-dependent manner. By contrast, the same myeloid DCs favor Th2 cell development in response to stimuli associated with parasites or allergens. For example, soluble egg Ags of helminth inhibit IL-12 production from monocyte-derived DCs and then induce DC-mediated Th2 responses through an OX40L-dependent mechanism (11). Furthermore, human thymic stromal lymphopoietin, which is highly expressed in epithelial tissues of atopic dermatitis, activates the blood myeloid DC subset to produce the Th2-attracting chemokines thymus- and activation-regulated chemokine and macrophage-derived chemokine, but not IL-12, and thymic stromal lymphopoietin-activated DCs instruct naive CD4+ T cells to differentiate into Th2 effector cells (41, 42). In parallel with the functional plasticity of myeloid DCs, the current study findings indicate that PDCs could induce Th1-type immune responses against microbial invasion (i.e., in response to virus or CpG DNA) and induce Th2 responses in an IL-3 milieu (which is generally formed under some allergic conditions) depending on PDC-derived IFN- and OX40L, respectively.
It is of note that PDCs are speculated to directly enter lymphoid tissues or inflammatory lesions, such as allergic mucosa from peripheral blood, in an L-selectin-dependent manner (2, 3, 43). IL-3 stimulation alone only weakly evoked OX40L expression on PCs. However, CD40L, which is delivered from T cells, substantially up-regulated its expression (Fig. 3). Therefore, it is suggested that in in vivo situations such as inflammations against allergens or parasites, PDCs may optimize their Th2-inducing ability through interaction with T cells in an IL-3 milieu. During the maturation in response to Sendai virus, the ability of PDCs to residually produce IFN- was down-regulated (Fig. 2), whereas the expression level of OX40L on PDCs was up-regulated (Fig. 3B). In accordance with these findings, PDCs with prolonged stimulation of Sendai virus (3d-SV-PDCs) could instruct naive Th cells to more actively produce Th2 cytokines than 1d-SV-PDCs (Fig. 1). This may lead to a scenario in which viral infection causes the PDC-mediated Th1-type responses in the early phase of immune responses, and thereafter induces some potential to mount Th2 responses, which may contribute to eliciting an immunological memory and/or counteracting the overload of Th1 responses. Furthermore, the Th2 responses may also induce the humoral immunity against viruses. Immunity against viruses involves Ab production, induction of cellular effectors such as CTL, and cytokines including IFN- and IFN-. The findings obtained in this study suggest that PCs/PDCs are closely related to the mechanisms of antiviral immunity described above. Thus, PDCs could dictate the quality of Th responses depending on the balance of IFN- and OX40L expressions.
In conclusion, the current study delineated a biological significance of OX40L and type I IFNs in PDCs in regulating Th responses. Therefore, the findings obtained in this study may not only offer a new insight into the essential nature of PDCs, but also be helpful in understanding the etiological importance of PDCs in various diseases and thus in establishing a new therapeutic strategy for the diseases.
|
Footnotes |
|---|
2 Address correspondence and reprint requests to Dr. Ryuichi Amakawa, First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizono-cho, Moriguchi City, Osaka 570-8506, Japan. E-mail address: amakawa{at}takii.kmu.ac.jp
3 Abbreviations used in this paper: PC, plasmacytoid cell; CD40L, CD40 ligand; 1d-SV-PDC, PDC prestimulated with Sendai virus for 1 day; DC, dendritic cell; OX40L, OX40 ligand; PDC, plasmacytoid DC; sCD40, soluble CD40.
Received for publication May 14, 2003. Accepted for publication January 22, 2004.
|
References |
|---|
|
TopAbstractIntroductionMaterials and MethodsResultsDiscussionReferences |
|---|
/-producing cells link innate and adaptive immunity. J. Exp. Med. 192:219./ in plasmacytoid dendritic cells. Eur. J. Immunol. 31:2154.[Medline]
and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195:1507. increases the frequency of interferon -producing human CD4+ T cells. J. Exp. Med. 178:1655.This article has been cited by other articles:
|
|
 |
|
  C-H. Hung, Y-T. Chu, J-L. Suen, M-S. Lee, H-W. Chang, Y-C. Lo, and Y-J. Jong Regulation of cytokine expression in human plasmacytoid dendritic cells by prostaglandin I2 analogues Eur. Respir. J., February 1, 2009; 33(2): 405 - 410. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. K. Pfaller and K.-K. Conzelmann Measles Virus V Protein Is a Decoy Substrate for I{kappa}B Kinase {alpha} and Prevents Toll-Like Receptor 7/9-Mediated Interferon Induction J. Virol., December 15, 2008; 82(24): 12365 - 12373. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Bjorck, A. Beilhack, E. I. Herman, R. S. Negrin, and E. G. Engleman Plasmacytoid Dendritic Cells Take Up Opsonized Antigen Leading to CD4+ and CD8+ T Cell Activation In Vivo J. Immunol., September 15, 2008; 181(6): 3811 - 3817. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Li, S. Liu, T. Zhang, W. Pan, X. Yang, and X. Cao Splenic Stromal Microenvironment Negatively Regulates Virus-Activated Plasmacytoid Dendritic Cells through TGF-{beta} J. Immunol., March 1, 2008; 180(5): 2951 - 2956. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Veckman and I. Julkunen Streptococcus pyogenes activates human plasmacytoid and myeloid dendritic cells J. Leukoc. Biol., February 1, 2008; 83(2): 296 - 304. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Takahashi, S. Satoi, H. Yanagimoto, N. Terakawa, H. Toyokawa, T. Yamamoto, Y. Matsui, S. Takai, A-H. Kwon, and Y. Kamiyama Circulating Dendritic Cells and Development of Septic Complications After Pancreatectomy for Pancreatic Cancer Arch Surg, December 1, 2007; 142(12): 1151 - 1157. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Ito, M. Yang, Y.-H. Wang, R. Lande, J. Gregorio, O. A Perng, X.-F. Qin, Y.-J. Liu, and M. Gilliet Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand J. Exp. Med., January 22, 2007; 204(1): 105 - 115. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Kurooka and Y. Kaneda Inactivated Sendai Virus Particles Eradicate Tumors by Inducing Immune Responses through Blocking Regulatory T Cells Cancer Res., January 1, 2007; 67(1): 227 - 236. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. Popovic, R. DeMarco, M. T. Lotze, S. E. Winikoff, D. L. Bartlett, A. M. Krieg, Z. S. Guo, C. K. Brown, K. J. Tracey, and H. J. Zeh III High Mobility Group B1 Protein Suppresses the Human Plasmacytoid Dendritic Cell Response to TLR9 Agonists J. Immunol., December 15, 2006; 177(12): 8701 - 8707. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Allman, M. Dalod, C. Asselin-Paturel, T. Delale, S. H. Robbins, G. Trinchieri, C. A. Biron, P. Kastner, and S. Chan Ikaros is required for plasmacytoid dendritic cell differentiation Blood, December 15, 2006; 108(13): 4025 - 4034. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. J. Masten, G. K. Olson, C. A. Tarleton, C. Rund, M. Schuyler, R. Mehran, T. Archibeque, and M. F. Lipscomb Characterization of Myeloid and Plasmacytoid Dendritic Cells in Human Lung J. Immunol., December 1, 2006; 177(11): 7784 - 7793. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kitawaki, N. Kadowaki, N. Sugimoto, N. Kambe, T. Hori, Y. Miyachi, T. Nakahata, and T. Uchiyama IgE-activated mast cells in combination with pro-inflammatory factors induce Th2-promoting dendritic cells Int. Immunol., December 1, 2006; 18(12): 1789 - 1799. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. J. Montoya, H.-B. Jie, L. Al-Harthi, C. Mulder, P. J. Patino, M. T. Rugeles, A. M. Krieg, A. L. Landay, and S. B. Wilson Activation of Plasmacytoid Dendritic Cells with TLR9 Agonists Initiates Invariant NKT Cell-Mediated Cross-Talk with Myeloid Dendritic Cells J. Immunol., July 15, 2006; 177(2): 1028 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Mima, S. Yamamoto, M. Ito, R. Tomoshige, Y. Tabata, K. Tamai, and Y. Kaneda Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector. Mol. Cancer Ther., April 1, 2006; 5(4): 1021 - 1028. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Agostini, E. Cenci, E. Pericolini, G. Nocentini, G. Bistoni, A. Vecchiarelli, and C. Riccardi The Glucocorticoid-Induced Tumor Necrosis Factor Receptor-Related Gene Modulates the Response to Candida albicans Infection Infect. Immun., November 1, 2005; 73(11): 7502 - 7508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Bendriss-Vermare, S. Burg, H. Kanzler, L. Chaperot, T. Duhen, O. de Bouteiller, M. D'agostini, J.-M. Bridon, I. Durand, J. M. Sederstrom, et al. Virus overrides the propensity of human CD40L-activated plasmacytoid dendritic cells to produce Th2 mediators through synergistic induction of IFN-{gamma} and Th1 chemokine production J. Leukoc. Biol., October 1, 2005; 78(4): 954 - 966. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Morita, T. Uchiyama, and T. Hori Nitric Oxide Inhibits IFN-{alpha} Production of Human Plasmacytoid Dendritic Cells Partly via a Guanosine 3',5'-Cyclic Monophosphate-Dependent Pathway J. Immunol., July 15, 2005; 175(2): 806 - 812. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Schlender, V. Hornung, S. Finke, M. Gunthner-Biller, S. Marozin, K. Brzozka, S. Moghim, S. Endres, G. Hartmann, and K.-K. Conzelmann Inhibition of Toll-Like Receptor 7- and 9-Mediated Alpha/Beta Interferon Production in Human Plasmacytoid Dendritic Cells by Respiratory Syncytial Virus and Measles Virus J. Virol., May 1, 2005; 79(9): 5507 - 5515. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Marcenaro, M. D. Chiesa, F. Bellora, S. Parolini, R. Millo, L. Moretta, and A. Moretta IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interactions with Dendritic Cells or Tumors J. Immunol., April 1, 2005; 174(7): 3992 - 3998. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. McKenna, A.-S. Beignon, and N. Bhardwaj Plasmacytoid Dendritic Cells: Linking Innate and Adaptive Immunity J. Virol., January 1, 2005; 79(1): 17 - 27. [Full Text] [PDF]
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
MFI), which is calculated by subtraction of the MFI with the isotype-matched control from that with each mAb. The data shown are representative of three independent experiments. B and C, The PDCs were cocultured with allogeneic CD4+ naive T cells for 7 days, then T cells were restimulated with PMA and ionomycin. The T cell cytokine profile was analyzed intracellularly by flow cytometry (B) and measured in supernatants by ELISA (C; details in Materials and Methods). B, The percentages of the respective cytokine-producing T cells are indicated in each dot-blot profile. This figure represents the results from one of four experiments. C, Results are shown as the mean ± SEM of four experiments.
